SARS-CoV-2 inactivated viral vaccine

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS VIRAL VECTOR
EP 4151232 A4申请人: LABORATORIO AVI MEX S A DE C V优先权: 2020
CN
EP
US
WO
5 件公开
ORAL THERAPEUTIC VACCINE COMPOSITIONS, METHODS AND TREATMENT OF COVID
EP 4437110 A4申请人: IMMUNITOR THAILAND CO LTD优先权: 2021
EP
US
WO
3 件公开
PRODUCTION OF VACCINES COMPRISING INACTIVATED SARS-COV-2 VIRAL PARTICLES
EP 4114456 A1申请人: THE COLORADO STATE UNIV RESEARCH FOUNDATION优先权: 2020
EP
US
3 件公开
RECOMBINANT PROTEIN VACCINE FOR PREVENTING AND TREATING SARS-COV-2 VARIANTS JN.1, BA.2.86, AND XBB LINEAGES, DRUG FOR COMBINED USE, AND USE
WO 2025189658 A1申请人: WESTVAC BIOPHARMA CO LTD优先权: 2024
CN
WO
2 件公开
Non-integrating HIV-1 comprising mutant RT/IN proteins and the SARS-CoV-2 spike protein
US 11129890 B1申请人: VIGENE BIOSCIENCES INC优先权: 2020
US
Methods of controlling infectious diseases with vaccines
CN 117562989 A申请人: RACERVILLE CARDIOLOGY CONSULTING SERVICES优先权: 2022
CN